156 related articles for article (PubMed ID: 21539296)
21. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.
Glabe CG
Neurobiol Aging; 2006 Apr; 27(4):570-5. PubMed ID: 16481071
[TBL] [Abstract][Full Text] [Related]
22. Imaging amyloid fibrils within cells using a Se-labelling strategy.
Porter AE; Knowles TP; Muller K; Meehan S; McGuire E; Skepper J; Welland ME; Dobson CM
J Mol Biol; 2009 Oct; 392(4):868-71. PubMed ID: 19635483
[TBL] [Abstract][Full Text] [Related]
23. [Selected aspects of amyloidogenesis].
Stepkowski D
Postepy Biochem; 2012; 58(1):110-4. PubMed ID: 23214135
[TBL] [Abstract][Full Text] [Related]
24. Shape matters: the complex relationship between aggregation and toxicity in protein-misfolding diseases.
Ries HM; Nussbaum-Krammer C
Essays Biochem; 2016 Oct; 60(2):181-190. PubMed ID: 27744334
[TBL] [Abstract][Full Text] [Related]
25. Molecular pathogenesis of protein misfolding diseases: pathological molecular environments versus quality control systems against misfolded proteins.
Naiki H; Nagai Y
J Biochem; 2009 Dec; 146(6):751-6. PubMed ID: 19643812
[TBL] [Abstract][Full Text] [Related]
26. Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy.
Margittai M; Langen R
Q Rev Biophys; 2008; 41(3-4):265-97. PubMed ID: 19079806
[TBL] [Abstract][Full Text] [Related]
27. Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases.
Ferreira ST; Vieira MN; De Felice FG
IUBMB Life; 2007; 59(4-5):332-45. PubMed ID: 17505973
[TBL] [Abstract][Full Text] [Related]
28. Direct observation of nucleation and growth in amyloid self-assembly.
Liang Y; Lynn DG; Berland KM
J Am Chem Soc; 2010 May; 132(18):6306-8. PubMed ID: 20397724
[TBL] [Abstract][Full Text] [Related]
29. Experimental investigation of protein folding and misfolding.
Dobson CM
Methods; 2004 Sep; 34(1):4-14. PubMed ID: 15283911
[TBL] [Abstract][Full Text] [Related]
30. Roles of extracellular chaperones in amyloidosis.
Wyatt AR; Yerbury JJ; Dabbs RA; Wilson MR
J Mol Biol; 2012 Aug; 421(4-5):499-516. PubMed ID: 22248589
[TBL] [Abstract][Full Text] [Related]
31. Implications of protein structure instability: from physiological to pathological secondary structure.
Sukhanova A; Poly S; Shemetov A; Bronstein I; Nabiev I
Biopolymers; 2012 Aug; 97(8):577-88. PubMed ID: 22605549
[TBL] [Abstract][Full Text] [Related]
32. Protein aggregation: mechanisms and functional consequences.
Invernizzi G; Papaleo E; Sabate R; Ventura S
Int J Biochem Cell Biol; 2012 Sep; 44(9):1541-54. PubMed ID: 22713792
[TBL] [Abstract][Full Text] [Related]
33. Protein amyloidose misfolding: mechanisms, detection, and pathological implications.
Jeyashekar NS; Sadana A; Vo-Dinh T
Methods Mol Biol; 2005; 300():417-35. PubMed ID: 15657495
[TBL] [Abstract][Full Text] [Related]
34. Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases.
Cheng B; Gong H; Xiao H; Petersen RB; Zheng L; Huang K
Biochim Biophys Acta; 2013 Oct; 1830(10):4860-71. PubMed ID: 23820032
[TBL] [Abstract][Full Text] [Related]
35. A fluorescent pentameric thiophene derivative detects in vitro-formed prefibrillar protein aggregates.
Hammarström P; Simon R; Nyström S; Konradsson P; Aslund A; Nilsson KP
Biochemistry; 2010 Aug; 49(32):6838-45. PubMed ID: 20604540
[TBL] [Abstract][Full Text] [Related]
36. Retention of misfolded mutant transthyretin by the chaperone BiP/GRP78 mitigates amyloidogenesis.
Sörgjerd K; Ghafouri B; Jonsson BH; Kelly JW; Blond SY; Hammarström P
J Mol Biol; 2006 Feb; 356(2):469-82. PubMed ID: 16376939
[TBL] [Abstract][Full Text] [Related]
37. A strategy for designing a peptide probe for detection of β-amyloid oligomers.
Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR
Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399
[TBL] [Abstract][Full Text] [Related]
38. Quantitative feature extraction reveals the status quo of protein fibrillation in the cell nucleus.
Arnhold F; von Mikecz A
Integr Biol (Camb); 2011 Jul; 3(7):761-9. PubMed ID: 21687851
[TBL] [Abstract][Full Text] [Related]
39. Assessing the stability of Alzheimer's amyloid protofibrils using molecular dynamics.
Lemkul JA; Bevan DR
J Phys Chem B; 2010 Feb; 114(4):1652-60. PubMed ID: 20055378
[TBL] [Abstract][Full Text] [Related]
40. Conformation-dependent antibodies target diseases of protein misfolding.
Glabe CG
Trends Biochem Sci; 2004 Oct; 29(10):542-7. PubMed ID: 15450609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
